SA halts rollout of AstraZeneca vaccine over efficacy against second variant

Early scientific data released on Sunday revealed that the vaccine offered ‘minimal protection’ against mild disease for people infected with the second variant of the coronavirus discovered at the end of last year.

Read the full story: Read More